Aibreán 2023: Is é an sprioc atá leis an modh cóireála ailse tuar dóchais inti ar a dtugtar imdhíonteiripe insíothlú siadaí (TIL) córas imdhíonachta an chomhlachta a úsáid chun cealla ailse a chomhrac. Is éard atá i gceist leis an bpróiseas ná cealla imdhíonachta ar a dtugtar TILs a thógáil as fíochán meall an othair, iad a fhás agus a ghníomhachtú lasmuigh den chorp, agus ansin iad a thabhairt ar ais isteach san othar. Trí líon na gceall imdhíonachta a mhéadú is féidir cealla ailse a aithint agus a mharú, tá sé mar aidhm ag an teiripe seo siadaí a laghdú nó a dhíothú go hiomlán.
White blood cells known as TILs are an essential component of the body’s immune response against malignancies. Although these cells can identify and target cancer cells, their efficacy may be compromised in patients with advanced cancer. TILs are isolated from a patient’s tumour tissue sample and used in Teiripe TIL. To improve their capacity to identify and combat cancer cells, these cells are then cultivated in the lab and activated by signalling molecules such as cytokines.
The TILs are reintroduced into the patient’s body via infusion after being grown and activated. The TILs move to the siadaí location and start attacking cancer cells there. It is hoped that by raising the body’s TIL levels, the immune system will be better able to combat cancer.
A number of solid tumours, including melanoma, cervical cancer, and ovarian cancer, have responded favorably to TIL therapy in trialacha cliniciúla. There have been instances where the cancer has completely disappeared. To fully comprehend the therapy’s potential and constraints, additional research is required as it is still in the early phases of development.
Ceann de na dúshláin is mó a bhaineann le teiripe TIL ná na TILanna beachta a ionsaíonn cealla ailse is éifeachtaí a aimsiú. D’fhéadfadh cur i bhfeidhm forleathan TILanna a bheith srianta mar gheall ar a gcastacht agus fad na bpróiseas eastósctha, leathnaithe agus gníomhachtaithe a ídíonn am. Chun aghaidh a thabhairt ar na saincheisteanna seo, tá taighdeoirí ag féachaint ar bhealaí chun an nós imeachta asbhainte agus gníomhachtúcháin TIL a luathú agus chun cóireálacha níos indibhidiúlaithe, spriocdhírithe a sholáthar.
Tríd is tríd, is modh tuar dóchais inti é teiripe TIL chun ailse a chóireáil a bhfuil torthaí maithe bainte amach aici i réamhthrialacha cliniciúla. Mar gheall ar na buntáistí a d'fhéadfadh a bheith ag an teiripe seo tá sé ina réimse taighde suimiúil do chóireáil ailse sa todhchaí, in ainneoin go bhfuil constaicí iomadúla fós le réiteach.
Teiripe TILs san India
Some of the leading oncologists in India has started TILs therapy with the help of foreign collaborations. Several types of solid tumor cases like melanoma, sarcomas, gynec cancers, GI cancers can be cured with the help of TILs therapy.
Costas teiripe TILs san India
Braitheann costas teiripe TIL san India ar an gcineál ailse agus ar an ualach iomlán siadaí ar an othar. Braitheann sé go mór ar chás. Chun sonraí a fháil faoin gcostas seol tuairiscí leighis na n-othar chuig eolas@cancerfax.com nó ceangail ar WhatsApp le + 91 96 1588 1588.
